Median Technologies completes €50 million capital increase
Client(s) Median Technologies SA
Jones Day advised Median Technologies SA, a Euronext Growth Paris-listed developer of AI-powered software as a medical device for cancer diagnosis and provider of AI-based oncology imaging services, on its upsized €50 million capital increase, including a French public offering, international private placement to qualified investors, and reserved offering to certain backup investors.